Prognostic impact of BRCA mutation on metastasis-free survival in a localized/locoregional high-risk real-world prostate cancer population. The silent burden: A SEER-based analysis of potential years ...
A non-DRE, voided urine, genomic assay to diagnose prostate cancer and to assess its aggressiveness.
Comparing NCCN-based risk groups to the PROTEUS definition of high-risk localized prostate cancer to inform peri-operative care.
Jairam Eswara, MD, FACS, is a nationally recognized urology specialist and a Fellow of the American College of Surgeons. He’s the Chair of the Department of Urology at Tufts Medical Center and an ...
Hosted on MSN
Prostate Cancer Awareness Month 2025: Everything You Need To Know About A Prostate Exam & What To Expect
Every September, countries across the world observe Prostate Cancer Awareness Month to highlight the importance of prostate health and early detection. It was first declared by the American Foundation ...
Australian charity Movember has launched a campaign aimed at dispelling myths surrounding prostate cancer checks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results